Drug · DIN 02550989
ADHEROZA
KIT CONTAINING: A) VIAL AND B) DILUENT
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since September 22, 2026; first marketed September 22, 2026.
- Drug Identification Number (DIN)
- 02550989
- Company (DIN owner)
- Accord Healthcare IncKirkland, Quebec, Canada
- Schedule
- Schedule d; Prescription
- Dosage form
- Powder For Solution; Kit
- Route
- Intravenous
- Therapeutic class (ATC)
- Trastuzumab L01FD01
- Class
- Human
- Record last updated
- September 23, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| TRASTUZUMAB | 420 MG | VIAL |
Notices of Compliance
Health Canada approvals that name this DIN.
- August 20, 2024: NOC 33930New Drug Submission (NDS)
Other DINs named ADHEROZA
- DIN 02550970 · Approved